Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,050 | 1,590 | N/A | 210 | 2,870 |
| Other current assets | 350 | 370 | 110 | 200 | 20 |
| TOTAL | $1,400 | $1,960 | $110 | $410 | $2,890 |
| Non-Current Assets | |||||
| PPE Net | 140 | 10 | N/A | 140 | 300 |
| Other Non-Current Assets | 260 | 250 | 260 | 240 | 240 |
| TOTAL | $400 | $260 | $260 | $380 | $540 |
| Total Assets | $1,810 | $2,230 | $370 | $800 | $3,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 810 | 850 | 880 | 770 | 940 |
| Accrued Expenses | 400 | 110 | 90 | 130 | 140 |
| TOTAL | $1,210 | $970 | $970 | $900 | $1,080 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,070 | 0 | 0 | 0 | 0 |
| TOTAL | $1,070 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,290 | $970 | $970 | $900 | $1,080 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 60 | 20 | 20 | 20 |
| Retained earnings | -83,980 | -78,900 | N/A | -71,530 | -67,420 |
| Other shareholders' equity | 10 | 10 | 0 | 10 | 10 |
| TOTAL | $-480 | $1,260 | $77,800 | $-100 | $2,360 |
| Total Liabilities And Equity | $1,810 | $2,230 | $78,770 | $800 | $3,440 |